Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
240 participants
Study Classification
INTERVENTIONAL
Study Start Date
2015-10-31
Study Completion Date
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Traditionally, patients are kept nil-per-os (NPO) or nil-by-mouth (NBM) prior to invasive cardiac procedures. There exists neither clear evidence nor guidance about the benefits of this.
The investigators aim to assess if there is a reduced incidence of vasovagal complications (primary outcome) and the combined incidence of aspiration pneumonia, change in eGFR, participant satisfaction if participants are not kept fasting.
This (pilot) randomised control trial will have an intervention arm allowing participants to drink clear liquids freely up to 1 hour before the procedure versus keeping them traditionally NPO.
240 patients will be randomised with 120 participants in each arm.
The investigators aim to assess if there is a reduced incidence of vasovagal complications (primary outcome) and the combined incidence of aspiration pneumonia, change in eGFR, participant satisfaction if participants are not kept fasting.
This (pilot) randomised control trial will have an intervention arm allowing participants to drink clear liquids freely up to 1 hour before the procedure versus keeping them traditionally NPO.
240 patients will be randomised with 120 participants in each arm.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Ischemic Preconditioning in Cardiac Surgery Trial
NCT01071265
Cardiac Surgery
COMPLETED
NA
Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting
NCT00193999
Heart Disease
COMPLETED
PHASE4
Echocardiographic Assessment of Volume Variation Secondary to Preoperative Fasting
NCT01258361
Hypovolemia
COMPLETED
Registry Construction for Perioperative Data in Patients Undergoing Cardiovascular Surgery
NCT04136210
Cardiac Surgery
Anesthesia
COMPLETED
Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery
NCT04244981
Cardiac Surgical Procedures
RECRUITING
PHASE4
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Introduction, background and justification for the study
Patients are traditionally kept Nulla-Per-Os/Nil-By-Mouth (NPO/NBM) for 4-6 hours prior to cardiac procedures including: diagnostic coronary angiograms, right heart catheters, percutaneous coronary interventions and device therapies to minimize the risk of vomiting and pulmonary aspiration during sedation or general anesthesia. The risk of developing pulmonary aspiration is 0.0015 % following emergency coronary artery bypass (CABG) surgery in patients without pre-procedural fasting. There is currently no data available regarding the risk of aspiration during cardiac angiographic interventions, but the risk is likely lower than that of emergency CABG. Currently no North-American or European guidelines require patients to be fasted before cardiac procedures.
The incidence of emergency CABG following cardiac catheterization is between 0.15 % to 0.4 %, whilst that of cardiac arrest is about 1%. In the subset of patients who develop cardiac arrest during elective cardiac catheterization or PCI, the incidence of pulmonary aspiration is low and similar between survivors and non-survivors (8.9% of patients who developed cardiac arrest).
Unsurprisingly, patients admitted with acute MI undergoing Primary PCI (PPCI) are not fasted beforehand and the need for emergency intubation/CABG remains rare in these patients.
A study has shown a rare occurrence of pulmonary aspiration in general anesthesia with a risk of 0.02% for elective and 0.1% for emergency procedures. In two randomized controlled trials, no case of pulmonary aspiration was reported despite the absence of pre-procedure fasting and use of Midazolam/Diazepam/etomidate.
Similarly, in an observational study no patient developed pulmonary aspiration. A Cochrane review did not show an increased risk of pulmonary aspiration with shorter fluid fast. A review article did not report an increased risk of pulmonary aspiration in non-fasted patients in the emergency department. However, a prospective multicenter emergency-department study of 2623 patients revealed only one patient developed aspiration pneumonia following the use of sedation. There is current consensus in the anesthesia literature that it is safe for healthy individuals to drink clear fluids up to 2 hours before induction of general anesthesia. It is recommended that 2 hours fasting for clear fluids, 6 hours for solids and supports the concept of pre-operative oral nutrition using a special carbohydrate-rich beverage. On the other hand, coronary procedures require the use of intravenous contrast, which can precipitate acute renal impairment. It has been shown that proper hydration can reduce the risk of contrast-induced nephropathy. A review study suggests that the oral route is as effective as the intravenous route for volume expansion and reduction of contrast-induced acute kidney injury. A prospective study demonstrated that lack of fasting was not associated with a higher incidence of adverse events in children undergoing pre-procedural sedation in the emergency department. A recent clinical policy published by the American College of Emergency Physicians; has recommended (Level B), that procedural sedations in emergency departments should not be delayed based on fasting status.
Similarly, a recent retrospective study of 1900 patients in UK, demonstrated that patients do not need to be NPO prior to Percutaneous Coronary Intervention (PCI). Another study has demonstrated that reduced gastric pH (\<2.0) and increased gastric volumes predisposed to pulmonary aspiration. Invasive procedures such as angiography and angioplasty both are associated with a small risk of adverse events. One such adverse event is vasovagal reaction which occurs in 3-4% of patients and may be exacerbated by depletion of volume as seen in the fasted state .
Current status at the University Health Network UHN policy requires patients to fast for both solids and liquids for a minimum of 4 hours before cardiac catheterization.
The investigators explore a fasting protocol that is different from current UHN policy
Introduction, background and justification for the study:
UHN policy requires patients to fast for both solids and liquids for a minimum of 4 hours before cardiac catheterization.
The investigators explore a fasting protocol that is different from current UHN policy and have involved staff from both the cardiothoracic surgery and anesthesiology teams, who will also act as a safety monitor and be part of the Data Safety Monitoring Board to ensure that participants are safe from harm or adverse effects.
Currently there is no published data on the association between fasting state and peri-procedural vasovagal symptom reduction or procedural satisfaction.
Hypothesis:
A more liberal fasting protocol (fasting \> 4 hours for solid, but encouraging oral clear fluids up to 1 hour prior to the procedure) is associated with a lower incidence of peri-procedural vasovagal complications than current standard fasting protocol (\> 4 hours for both solids and fluids)
Methods and experimental design:
This is a prospective single-blind randomized pilot study. The Cardiac Interventionists involved in the procedure will be blinded to randomization. All patients undergoing cardiac invasive procedures will be screened for eligibility. The participants will be randomised to 2 groups (eligibility criteria and outcome measures are mentioned in a different section).
Study Groups Group 1 - Control Group: Participants will be fasted according to current standard practice at UHN (a minimum of 4 hours of fasting period for both liquids and solid food).
Group 2 - Intervention group: Participants will be allowed (and encouraged) to drink clear fluids up to 1 hour before the procedure. Solid foods will be allowed up to 4 hours before the procedure which is current standard practice at UHN.
Enrolment and randomization:
Participants who qualify for the study will be approached in person prior to (if in-patient) or on the day of the procedure (if ambulatory) to obtain written informed consent prior to randomization.
A verbal explanation and written information in the form of the patient information sheet will be given to participants. They will be approached by co-investigators who are not involved in their care and given at least 4-24 hours to consent for the study. They will have as much time as they need to consider the study. They will also have the opportunity to discuss it with their family, friends and family doctor.
They will be given contact details of the on-site research team including the study doctors and nurses who will be able to answer any of their queries at any point during the study. They will be notified that they are not obliged to participate in the study and if they do decide to take part and change their mind at any point they can withdraw from the study unconditionally and their withdrawal will not affect their future care.
Vulnerable groups will not be participating in this research hence no special measures will be taken for their recruitment. Participants will also be informed of any potential safety concern that may arise during the study and will be advised about further treatment options. Wherever possible the Hospitals translation service will be used to offer translation of the consent form to patients who do not have English as their first language. Other individuals, who require specialist communication such as the visually impaired or those who suffer from deafness will wherever possible, be accommodated with the hospitals on-site services.
Throughout the study the participant's identity will be protected and will not be disclosed outside the Hospital in keeping with the University Hospital Network (UHN) Patient Health Information (PHI) policy. At the beginning of the study the investigators will receive an identification log to enable them to record patient study pseudonymised identification numbers. This record will remain at the central research offices at the participating centers and will act as a reference document for the PI. Data from the case report forms (CRFs) will be stored on an onsite computer. The hard copy CRFs will be kept in the research doctor's office -the persons able to access the case report forms will be the PI and the cardiology research doctors and nurses delegated for this study purpose.
Follow up:
Participants will be requested to return for one blood test between day 3 and day 5 post- procedure. To and from public transport cost will be provided to the patient and one accompanying person if needed. A telephonic follow up will also be undertaken at one week to ensure no adverse events have occurred.
Baseline investigations/Information:
At the time of the procedure , the investigators will obtain and record the following:
Pre-procedural Information
1. Pre-procedure investigations (Hemoglobin, Urea, Creatinine, eGFR)
2. Patient demographics (Diabetes Mellitus {DM}, hypertension {HTN}, renal impairment, peripheral vascular disease {PVD})
3. Index admission diagnosis (NSTEMI, Chronic stable angina)
4. Weight, height and Body Mass Index (BMI)
5. Medications on admission
Procedural and post-procedural information will be recorded, including:
1. Type of procedure
2. Route (access site-femoral or radial) of procedure
3. Intra-procedural details (sedation, analgesia, complications, devices-used)
4. Procedural and post-procedural outcomes(Success, in-hospital complications, discharge time and date, complications including mortality and aspiration pneumonia)
5. Patient satisfaction survey
6. Post-procedural creatinine
7. Post-procedural telephonic call one week from date of procedure Statistical analysis Demographic and procedural variables will be presented as percentage (categorical variable) or mean ± SD (continuous variable). Comparison of demographic and procedural variables between the two groups will be performed by chi-square or Fisher's exact test for categorical variables and student's t test for continuous variables. Statistical analysis will be performed using SPSS version 22. Randomization will be performed by systematic random sampling by utilizing an online computer generated random number assignment tool.
Sample size calculation:
Sample size was calculated based on proportion and effect size. A total sample size of 240 patients (120 patients in each arm) would have an 80 % power to detect a 1.0% incidence of vasovagal reaction in the intervention arm (for an α of 0.05).
Funding:
This study is being funded by the UHN Innovation Committee. Once the outcomes of the pilot study are available and if safety endpoints are accomplished, , the investigators will consider conducting a similar multicentre study.
Ethics:
All aspects of Good Clinical Practice will be adhered to. Patient confidentiality will be maintained as per the data protection policy including anonymising data. Ethical approval has been obtained from the REB through routine channels (CAPCR).
Patients are traditionally kept Nulla-Per-Os/Nil-By-Mouth (NPO/NBM) for 4-6 hours prior to cardiac procedures including: diagnostic coronary angiograms, right heart catheters, percutaneous coronary interventions and device therapies to minimize the risk of vomiting and pulmonary aspiration during sedation or general anesthesia. The risk of developing pulmonary aspiration is 0.0015 % following emergency coronary artery bypass (CABG) surgery in patients without pre-procedural fasting. There is currently no data available regarding the risk of aspiration during cardiac angiographic interventions, but the risk is likely lower than that of emergency CABG. Currently no North-American or European guidelines require patients to be fasted before cardiac procedures.
The incidence of emergency CABG following cardiac catheterization is between 0.15 % to 0.4 %, whilst that of cardiac arrest is about 1%. In the subset of patients who develop cardiac arrest during elective cardiac catheterization or PCI, the incidence of pulmonary aspiration is low and similar between survivors and non-survivors (8.9% of patients who developed cardiac arrest).
Unsurprisingly, patients admitted with acute MI undergoing Primary PCI (PPCI) are not fasted beforehand and the need for emergency intubation/CABG remains rare in these patients.
A study has shown a rare occurrence of pulmonary aspiration in general anesthesia with a risk of 0.02% for elective and 0.1% for emergency procedures. In two randomized controlled trials, no case of pulmonary aspiration was reported despite the absence of pre-procedure fasting and use of Midazolam/Diazepam/etomidate.
Similarly, in an observational study no patient developed pulmonary aspiration. A Cochrane review did not show an increased risk of pulmonary aspiration with shorter fluid fast. A review article did not report an increased risk of pulmonary aspiration in non-fasted patients in the emergency department. However, a prospective multicenter emergency-department study of 2623 patients revealed only one patient developed aspiration pneumonia following the use of sedation. There is current consensus in the anesthesia literature that it is safe for healthy individuals to drink clear fluids up to 2 hours before induction of general anesthesia. It is recommended that 2 hours fasting for clear fluids, 6 hours for solids and supports the concept of pre-operative oral nutrition using a special carbohydrate-rich beverage. On the other hand, coronary procedures require the use of intravenous contrast, which can precipitate acute renal impairment. It has been shown that proper hydration can reduce the risk of contrast-induced nephropathy. A review study suggests that the oral route is as effective as the intravenous route for volume expansion and reduction of contrast-induced acute kidney injury. A prospective study demonstrated that lack of fasting was not associated with a higher incidence of adverse events in children undergoing pre-procedural sedation in the emergency department. A recent clinical policy published by the American College of Emergency Physicians; has recommended (Level B), that procedural sedations in emergency departments should not be delayed based on fasting status.
Similarly, a recent retrospective study of 1900 patients in UK, demonstrated that patients do not need to be NPO prior to Percutaneous Coronary Intervention (PCI). Another study has demonstrated that reduced gastric pH (\<2.0) and increased gastric volumes predisposed to pulmonary aspiration. Invasive procedures such as angiography and angioplasty both are associated with a small risk of adverse events. One such adverse event is vasovagal reaction which occurs in 3-4% of patients and may be exacerbated by depletion of volume as seen in the fasted state .
Current status at the University Health Network UHN policy requires patients to fast for both solids and liquids for a minimum of 4 hours before cardiac catheterization.
The investigators explore a fasting protocol that is different from current UHN policy
Introduction, background and justification for the study:
UHN policy requires patients to fast for both solids and liquids for a minimum of 4 hours before cardiac catheterization.
The investigators explore a fasting protocol that is different from current UHN policy and have involved staff from both the cardiothoracic surgery and anesthesiology teams, who will also act as a safety monitor and be part of the Data Safety Monitoring Board to ensure that participants are safe from harm or adverse effects.
Currently there is no published data on the association between fasting state and peri-procedural vasovagal symptom reduction or procedural satisfaction.
Hypothesis:
A more liberal fasting protocol (fasting \> 4 hours for solid, but encouraging oral clear fluids up to 1 hour prior to the procedure) is associated with a lower incidence of peri-procedural vasovagal complications than current standard fasting protocol (\> 4 hours for both solids and fluids)
Methods and experimental design:
This is a prospective single-blind randomized pilot study. The Cardiac Interventionists involved in the procedure will be blinded to randomization. All patients undergoing cardiac invasive procedures will be screened for eligibility. The participants will be randomised to 2 groups (eligibility criteria and outcome measures are mentioned in a different section).
Study Groups Group 1 - Control Group: Participants will be fasted according to current standard practice at UHN (a minimum of 4 hours of fasting period for both liquids and solid food).
Group 2 - Intervention group: Participants will be allowed (and encouraged) to drink clear fluids up to 1 hour before the procedure. Solid foods will be allowed up to 4 hours before the procedure which is current standard practice at UHN.
Enrolment and randomization:
Participants who qualify for the study will be approached in person prior to (if in-patient) or on the day of the procedure (if ambulatory) to obtain written informed consent prior to randomization.
A verbal explanation and written information in the form of the patient information sheet will be given to participants. They will be approached by co-investigators who are not involved in their care and given at least 4-24 hours to consent for the study. They will have as much time as they need to consider the study. They will also have the opportunity to discuss it with their family, friends and family doctor.
They will be given contact details of the on-site research team including the study doctors and nurses who will be able to answer any of their queries at any point during the study. They will be notified that they are not obliged to participate in the study and if they do decide to take part and change their mind at any point they can withdraw from the study unconditionally and their withdrawal will not affect their future care.
Vulnerable groups will not be participating in this research hence no special measures will be taken for their recruitment. Participants will also be informed of any potential safety concern that may arise during the study and will be advised about further treatment options. Wherever possible the Hospitals translation service will be used to offer translation of the consent form to patients who do not have English as their first language. Other individuals, who require specialist communication such as the visually impaired or those who suffer from deafness will wherever possible, be accommodated with the hospitals on-site services.
Throughout the study the participant's identity will be protected and will not be disclosed outside the Hospital in keeping with the University Hospital Network (UHN) Patient Health Information (PHI) policy. At the beginning of the study the investigators will receive an identification log to enable them to record patient study pseudonymised identification numbers. This record will remain at the central research offices at the participating centers and will act as a reference document for the PI. Data from the case report forms (CRFs) will be stored on an onsite computer. The hard copy CRFs will be kept in the research doctor's office -the persons able to access the case report forms will be the PI and the cardiology research doctors and nurses delegated for this study purpose.
Follow up:
Participants will be requested to return for one blood test between day 3 and day 5 post- procedure. To and from public transport cost will be provided to the patient and one accompanying person if needed. A telephonic follow up will also be undertaken at one week to ensure no adverse events have occurred.
Baseline investigations/Information:
At the time of the procedure , the investigators will obtain and record the following:
Pre-procedural Information
1. Pre-procedure investigations (Hemoglobin, Urea, Creatinine, eGFR)
2. Patient demographics (Diabetes Mellitus {DM}, hypertension {HTN}, renal impairment, peripheral vascular disease {PVD})
3. Index admission diagnosis (NSTEMI, Chronic stable angina)
4. Weight, height and Body Mass Index (BMI)
5. Medications on admission
Procedural and post-procedural information will be recorded, including:
1. Type of procedure
2. Route (access site-femoral or radial) of procedure
3. Intra-procedural details (sedation, analgesia, complications, devices-used)
4. Procedural and post-procedural outcomes(Success, in-hospital complications, discharge time and date, complications including mortality and aspiration pneumonia)
5. Patient satisfaction survey
6. Post-procedural creatinine
7. Post-procedural telephonic call one week from date of procedure Statistical analysis Demographic and procedural variables will be presented as percentage (categorical variable) or mean ± SD (continuous variable). Comparison of demographic and procedural variables between the two groups will be performed by chi-square or Fisher's exact test for categorical variables and student's t test for continuous variables. Statistical analysis will be performed using SPSS version 22. Randomization will be performed by systematic random sampling by utilizing an online computer generated random number assignment tool.
Sample size calculation:
Sample size was calculated based on proportion and effect size. A total sample size of 240 patients (120 patients in each arm) would have an 80 % power to detect a 1.0% incidence of vasovagal reaction in the intervention arm (for an α of 0.05).
Funding:
This study is being funded by the UHN Innovation Committee. Once the outcomes of the pilot study are available and if safety endpoints are accomplished, , the investigators will consider conducting a similar multicentre study.
Ethics:
All aspects of Good Clinical Practice will be adhered to. Patient confidentiality will be maintained as per the data protection policy including anonymising data. Ethical approval has been obtained from the REB through routine channels (CAPCR).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Fasting
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
TREATMENT
Blinding Strategy
SINGLE
Investigators
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Fasting
Group 1(control group) Fasting for both solids and fluids for up to 4 hours pre-procedure
Group Type
NO_INTERVENTION
No interventions assigned to this group
Group 2 Non-fasting
Group 2 (intervention arm) Clear fluids up to 1 hour before the procedure and fasting for solids up to 4 hours pre-procedure
Group Type
EXPERIMENTAL
Non-fasting
Intervention Type
OTHER
Clear fluids up to 1hour pre-procedure and fasting for solids for up to 4 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-fasting
Clear fluids up to 1hour pre-procedure and fasting for solids for up to 4 hours
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Ability to give written informed consent
2. Diagnostic coronary angiography and coronary interventions (both elective and stable Acute Coronary Syndrome {ACS} patients).
3. ≥ 18 years of age
2. Diagnostic coronary angiography and coronary interventions (both elective and stable Acute Coronary Syndrome {ACS} patients).
3. ≥ 18 years of age
Exclusion Criteria
1. Patients who are intubated
2. Patients unable to give informed consent
3. Patients presenting with an acute unstable condition, including:
1. STEMI
2. unstable ACS
4. Patients with a history of or at risk for aspiration pneumonia
* stroke
* dysphagia
* severe gastroesophageal reflux disease
5. Patients with known or anticipated difficult airway
6. Patients who request to be allotted to a particular arm of the study
7. Patients who are temporary transfers from other hospitals
2. Patients unable to give informed consent
3. Patients presenting with an acute unstable condition, including:
1. STEMI
2. unstable ACS
4. Patients with a history of or at risk for aspiration pneumonia
* stroke
* dysphagia
* severe gastroesophageal reflux disease
5. Patients with known or anticipated difficult airway
6. Patients who request to be allotted to a particular arm of the study
7. Patients who are temporary transfers from other hospitals
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Health Network, Toronto
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Dzavik
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Toronto
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: a report by the American Society of Anesthesiologist Task Force on Preoperative Fasting. Anesthesiology. 1999 Mar;90(3):896-905. doi: 10.1097/00000542-199903000-00034. No abstract available.
Reference Type
BACKGROUND
Rosengarten J, Ozkor M, Knight C: Fasting and cardiac catheterization should we be following the evidence; Controversies and consensus in imaging and intervention (C2I2) 2007: V (2); 22-23
Reference Type
BACKGROUND
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7. No abstract available.
Reference Type
BACKGROUND
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI); Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29. No abstract available.
Reference Type
BACKGROUND
Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Coady P, Cohen H, Cowley M, Dorros G, Faxon D, Holmes DR, Jacobs A, Kelsey SF, King SB 3rd, Myler R, Slater J, Stanek V, Vlachos HA, Detre KM. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation. 2000 Dec 12;102(24):2945-51. doi: 10.1161/01.cir.102.24.2945.
Reference Type
BACKGROUND
Grayson AD, Moore RK, Jackson M, Rathore S, Sastry S, Gray TP, Schofield I, Chauhan A, Ordoubadi FF, Prendergast B, Stables RH; North West Quality Improvement Programme in Cardiac Interventions. Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England. Heart. 2006 May;92(5):658-63. doi: 10.1136/hrt.2005.066415. Epub 2005 Sep 13.
Reference Type
BACKGROUND
Webb JG, Solankhi NK, Chugh SK, Amin H, Buller CE, Ricci DR, Humphries K, Penn IM, Carere R. Incidence, correlates, and outcome of cardiac arrest associated with percutaneous coronary intervention. Am J Cardiol. 2002 Dec 1;90(11):1252-4. doi: 10.1016/s0002-9149(02)02846-1. No abstract available.
Reference Type
BACKGROUND
Nagel EL, Fine EG, Krischer JP, Davis JH. Complications of CPR. Crit Care Med. 1981 May;9(5):424. doi: 10.1097/00003246-198105000-00037. No abstract available.
Reference Type
BACKGROUND
Wharton TP Jr. Should patients with acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in community? The case for community hospital angioplasty. Circulation. 2005 Nov 29;112(22):3509-20; discussion 3534. doi: 10.1161/CIRCULATIONAHA.104.478362. No abstract available.
Reference Type
BACKGROUND
Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology. 1993 Jan;78(1):56-62. doi: 10.1097/00000542-199301000-00010.
Reference Type
BACKGROUND
Wright SW, Chudnofsky CR, Dronen SC, Kothari R, Birrer P, Blanton DM, Bruner A. Comparison of midazolam and diazepam for conscious sedation in the emergency department. Ann Emerg Med. 1993 Feb;22(2):201-5. doi: 10.1016/s0196-0644(05)80203-3.
Reference Type
BACKGROUND
Chan KLL. Etomidate and midazolam for procedural sedation in the emergency department of Queen Elizabeth Hospital: a randomised controlled trial. Hong Kong J Emerg Med 2008; 15: 75-87.
Reference Type
BACKGROUND
Dunn T, Mossop D, Newton A, Gammon A. Propofol for procedural sedation in the emergency department. Emerg Med J. 2007 Jul;24(7):459-61. doi: 10.1136/emj.2007.046714.
Reference Type
BACKGROUND
Brady M, Kinn S, Stuart P. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev. 2003;(4):CD004423. doi: 10.1002/14651858.CD004423.
Reference Type
BACKGROUND
Thorpe RJ, Benger J. Pre-procedural fasting in emergency sedation. Emerg Med J. 2010 Apr;27(4):254-61. doi: 10.1136/emj.2008.069120.
Reference Type
BACKGROUND
Taylor DM, Bell A, Holdgate A, MacBean C, Huynh T, Thom O, Augello M, Millar R, Day R, Williams A, Ritchie P, Pasco J. Risk factors for sedation-related events during procedural sedation in the emergency department. Emerg Med Australas. 2011 Aug;23(4):466-73. doi: 10.1111/j.1742-6723.2011.01419.x. Epub 2011 May 17.
Reference Type
BACKGROUND
Maltby JR, Sutherland AD, Sale JP, Shaffer EA. Preoperative oral fluids: is a five-hour fast justified prior to elective surgery? Anesth Analg. 1986 Nov;65(11):1112-6.
Reference Type
BACKGROUND
Phillips S, Hutchinson S, Davidson T. Preoperative drinking does not affect gastric contents. Br J Anaesth. 1993 Jan;70(1):6-9. doi: 10.1093/bja/70.1.6.
Reference Type
BACKGROUND
Soreide E, Eriksson LI, Hirlekar G, Eriksson H, Henneberg SW, Sandin R, Raeder J; (Task Force on Scandinavian Pre-operative Fasting Guidelines, Clinical Practice Committee Scandinavian Society of Anaesthesiology and Intensive Care Medicine). Pre-operative fasting guidelines: an update. Acta Anaesthesiol Scand. 2005 Sep;49(8):1041-7. doi: 10.1111/j.1399-6576.2005.00781.x.
Reference Type
BACKGROUND
Hausel J, Nygren J, Lagerkranser M, Hellstrom PM, Hammarqvist F, Almstrom C, Lindh A, Thorell A, Ljungqvist O. A carbohydrate-rich drink reduces preoperative discomfort in elective surgery patients. Anesth Analg. 2001 Nov;93(5):1344-50. doi: 10.1097/00000539-200111000-00063.
Reference Type
BACKGROUND
McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997 Nov;103(5):368-75. doi: 10.1016/s0002-9343(97)00150-2.
Reference Type
BACKGROUND
Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One. 2013;8(3):e60009. doi: 10.1371/journal.pone.0060009. Epub 2013 Mar 26.
Reference Type
BACKGROUND
Agrawal D, Manzi SF, Gupta R, Krauss B. Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department. Ann Emerg Med. 2003 Nov;42(5):636-46. doi: 10.1016/s0196-0644(03)00516-x.
Reference Type
BACKGROUND
Godwin SA, Burton JH, Gerardo CJ, Hatten BW, Mace SE, Silvers SM, Fesmire FM; American College of Emergency Physicians. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014 Feb;63(2):247-58.e18. doi: 10.1016/j.annemergmed.2013.10.015.
Reference Type
BACKGROUND
Hamid T, Aleem Q, Lau Y, Singh R, McDonald J, Macdonald JE, Sastry S, Arya S, Bainbridge A, Mudawi T, Balachandran K. Pre-procedural fasting for coronary interventions: is it time to change practice? Heart. 2014 Apr;100(8):658-61. doi: 10.1136/heartjnl-2013-305289. Epub 2014 Feb 12.
Reference Type
BACKGROUND
MENDELSON CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946 Aug;52:191-205. doi: 10.1016/s0002-9378(16)39829-5. No abstract available.
Reference Type
BACKGROUND
Dharma S, Shah S, Radadiya R, Vyas C, Pancholy S, Patel T. Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach. J Invasive Cardiol. 2012 Mar;24(3):122-5.
Reference Type
BACKGROUND
Epstein SE, Stampfer M, Beiser GD. Role of the capacitance and resistance vessels in vasovagal syncope. Circulation. 1968 Apr;37(4):524-33. doi: 10.1161/01.cir.37.4.524. No abstract available.
Reference Type
BACKGROUND
Sander-Jensen K, Secher NH, Bie P, Warberg J, Schwartz TW. Vagal slowing of the heart during haemorrhage: observations from 20 consecutive hypotensive patients. Br Med J (Clin Res Ed). 1986 Feb 8;292(6517):364-6. doi: 10.1136/bmj.292.6517.364.
Reference Type
BACKGROUND
S. B. Hulley, S. R. Cummings, W. S. Browner, et al: Designing Clinical Research: Fourth Edition, LWW, 2013.
Reference Type
BACKGROUND
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. doi: 10.1016/j.jacc.2004.06.068.
Reference Type
BACKGROUND
Perlas A, Mitsakakis N, Liu L, Cino M, Haldipur N, Davis L, Cubillos J, Chan V. Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesth Analg. 2013 Feb;116(2):357-63. doi: 10.1213/ANE.0b013e318274fc19. Epub 2013 Jan 9.
Reference Type
BACKGROUND
Cubillos J, Tse C, Chan VW, Perlas A. Bedside ultrasound assessment of gastric content: an observational study. Can J Anaesth. 2012 Apr;59(4):416-23. doi: 10.1007/s12630-011-9661-9. Epub 2012 Jan 4.
Reference Type
BACKGROUND
Perlas A, Van de Putte P, Van Houwe P, Chan VW. I-AIM framework for point-of-care gastric ultrasound. Br J Anaesth. 2016 Jan;116(1):7-11. doi: 10.1093/bja/aev113. Epub 2015 May 7. No abstract available.
Reference Type
BACKGROUND
Kruisselbrink R, Arzola C, Endersby R, Tse C, Chan V, Perlas A. Intra- and interrater reliability of ultrasound assessment of gastric volume. Anesthesiology. 2014 Jul;121(1):46-51. doi: 10.1097/ALN.0000000000000193.
Reference Type
BACKGROUND
Related Links
Access external resources that provide additional context or updates about the study.
http://www.sample-size.net/proportions-effect-size/
Sample size calculation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-8178-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Plasma Utilization Following Cardiac Surgery
NCT01187394
COMPLETED
Evaluation of Different Priming Solutions Effects on Microcirculation, Oxidative Stress and Morbidity in Cardiovascular Surgery Patients
NCT02501681
COMPLETED
PHASE4
Study on the Correlation Between Intraoperative Hypotension and Postoperative Myocardial Injury
NCT07094321
ACTIVE_NOT_RECRUITING
Norepinephrine Prevent Post-induction Hypotension in High-risk Patients
NCT06028256
UNKNOWN
PHASE4
Long Term Cardiovascular Disease Event Risk for Patients Undergoing Major Non-Cardiac Surgery
NCT05732714
RECRUITING
Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures
NCT00646373
TERMINATED
NA
Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study
NCT00546390
COMPLETED
NA
Permissive Hypotension After Cardiac Surgery
NCT06476613
ACTIVE_NOT_RECRUITING
NA
Postoperative Remote Monitoring of Vital Signs in Older Cardiac Surgery Patients
NCT03944967
COMPLETED
Fluid Infusion During Breast Surgery
NCT00431743
UNKNOWN
PHASE4
Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery
NCT01432184
COMPLETED
NA
Evaluation of the Corrected Carotid Flow Time and the Inferior Vena Cava Collapsibility Index in Predicting Post-spinal Anesthesia Hypotension in Geriatric Patients
NCT05759533
COMPLETED
Analysis of the Interaction Between Preoperative Lifestyle and Clinical Characteristics of Cardiac Surgery Patients and Perioperative Complications
NCT06991218
COMPLETED
Predictors of Perioperative Cardiac Morbidity
NCT00005197
COMPLETED
The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery
NCT00997217
COMPLETED
PHASE1
Cerebral Autoregulation Monitoring During Cardiac Surgery
NCT00981474
COMPLETED
NA
Preoperative Evaluation of Microcirculation for Prediction of Complications After Cardiac Surgery
NCT03631797
COMPLETED
NA
Effect of Preoperative Oral Carbohydrate on Hypotension After Anesthesia Induction in Elderly Patients With Joint Replacement
NCT05749328
UNKNOWN
NA
The Prognostic Capabilities Of A Preoperative Six-Minute Walk Test To Independently Inform Cardiovascular Risk After Major Noncardiac Surgery
NCT02860754
UNKNOWN
NA
Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery
NCT01534364
COMPLETED
NA
Cerebral Oximetry in Cardiac Surgery to Reduce Neurological Impairment and Hospital Length-of-stay
NCT04463563
COMPLETED
NA
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
NCT01328912
COMPLETED
PHASE3
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.
NCT04812717
RECRUITING
NA
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
NCT05881564
RECRUITING
NA